Skan Research Lab Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 2.73 M
as on 12-12-2024
- Company Age 20 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.41 Cr
as on 12-12-2024
- Revenue -7.97%
(FY 2021)
- Profit -27.76%
(FY 2021)
- Ebitda 16.78%
(FY 2021)
- Net Worth 14.46%
(FY 2021)
- Total Assets 13.03%
(FY 2021)
About Skan Research Lab
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.73 M.
The company currently has active open charges totaling ₹5.41 Cr.
Thirunagari Nallamuthiahpillai, Ramarao Narasimman, Subramanian Ananthanarayanan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231PY2004PTC001829
- Company No.
001829
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skan Research Lab?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thirunagari Nallamuthiahpillai  | Director | 02-Mar-2009 | Current |
| Ramarao Narasimman | Director | 01-Jun-2011 | Current |
| Subramanian Ananthanarayanan | Director | 05-Dec-2007 | Current |
| Saikrishnan | Whole-Time Director | 30-Dec-2020 | Current |
Financial Performance of Skan Research Lab.
Skan Research Lab Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.97% decrease. The company also saw a substantial fall in profitability, with a 27.76% decrease in profit. The company's net worth Soared by an impressive increase of 14.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skan Research Lab?
In 2021, Skan Research Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skn Organics Private LimitedActive 19 years 10 monthsThirunagari Nallamuthiahpillai and Ramarao Narasimman are mutual person
Jayashree Kalyani Agencies Private LimitedActive 15 years 1 monthThirunagari Nallamuthiahpillai and Saikrishnan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Aug 2022 | ₹0.59 M | Open |
State Bank Of India Creation Date: 22 Jun 2006 | ₹5.35 Cr | Open |
How Many Employees Work at Skan Research Lab?
Skan Research Lab has a workforce of 78 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skan Research Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skan Research Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
